This cascade is active in many cancers, due to phosphorylation and inactivation of the NF-κB inhibitor IκBα, allowing the NF-κB p50-p65 heterodimer to enter the nucleus and drive transcription of proproliferative factors including TNF-α (38, 44, 45). Here, NFKB1 is linked to cancer.